Skip to main content

Table 2 Clinical outcomes in all patients

From: Successful revascularization versus medical therapy in diabetic patients with stable right coronary artery chronic total occlusion: a retrospective cohort study

 

CTO-MT

CTO-SR

P value

All cause death

 Event per 1000 patient-years

28.05

12.17

0.000

 Unadjusted HR (95% CI)

1

0.423 (0.270–0.663)

0.000

 Adjusted HR (95% CI) Model 1

1

0.429 (0.269–0.682)

0.000

 Adjusted HR (95% CI) Model 2

1

0.445 (0.278–0.714)

0.001

Noncardiac death

 Event per 1000 patient-years

5.82

5.28

0.808

 Unadjusted HR (95% CI)

1

0.829 (0.370–1.860)

0.649

 Adjusted HR (95% CI) Model 1

1

1.351 (0.538–3.392)

0.522

 Adjusted HR (95% CI) Model 2

1

1.778 (0.684–4.618)

0.237

Cardiac death

 Event per 1000 patient-years

22.23

6.90

0.000

 Unadjusted HR (95% CI)

1

0.311 (0.177–0.547)

0.000

 Adjusted HR (95% CI) Model 1

1

0.308 (0.172–0.550)

0.000

 Adjusted HR (95% CI) Model 2

1

0.307 (0.169–0.557)

0.000

Probable/definite cardiac death

 Event per 1000 patient-years

12.17

3.65

0.000

 Unadjusted HR (95% CI)

1

0.297 (0.137–0.644)

0.002

 Adjusted HR (95% CI) Model 1

1

0.309 (0.138–0.693)

0.004

 Adjusted HR (95% CI) Model 2

1

0.341 (0.151–0.771)

0.010

Repeat nonfatal MI

 Event per 1000 patient-years

13.58

7.00

0.031

 Unadjusted HR (95% CI)

1

0.493 (0.266–0.915)

0.025

 Adjusted HR (95% CI) Model 1

1

0.466 (0.245–0.888)

0.020

 Adjusted HR (95% CI) Model 2

1

0.513 (0.264–0.998)

0.049

Repeat revascularization

 Event per 1000 patient-years

56.95

37.86

0.005

 Unadjusted HR (95% CI)

1

0.683 (0.509–0.915)

0.011

 Adjusted HR (95% CI) Model 1

1

0.689 (0.512–0.928)

0.014

 Adjusted HR (95% CI) Model 2

1

0.702 (0.516–0.955)

0.024

TVR

 Event per 1000 patient-years

36.13

20.48

0.002

 Unadjusted HR (95% CI)

1

0.591 (0.406–0.862)

0.006

 Adjusted HR (95% CI) Model 1

1

0.587 (0.401–0.858)

0.006

 Adjusted HR (95% CI) Model 2

1

0.613 (0.413–0.909)

0.015

  1. Adjusted covariates (model 1): age, CKD, COPD/asthma, prior MI, systolic HF, LVEF, reginal wall motion abnormality, single vessel disease, triple-vessel disease and syntax scores
  2. Adjusted covariates (model 2): age, sex, PVD, CKD, COPD/asthma, prior MI, systolic HF, LVEF, reginal wall motion abnormality, single vessel disease, triple-vessel disease, syntax scores and HbA1c
  3. HR hazard ratio, CI conference interval; other abbreviations as in Table 1